BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11884559)

  • 1. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
    West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
    J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein.
    Egan MA; Carruth LM; Rowell JF; Yu X; Siliciano RF
    J Virol; 1996 Oct; 70(10):6547-56. PubMed ID: 8794289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions.
    Akari H; Fukumori T; Adachi A
    J Virol; 2000 May; 74(10):4891-3. PubMed ID: 10775630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
    Chen SS; Ferrante AA; Terwilliger EF
    Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    Yu X; Yuan X; McLane MF; Lee TH; Essex M
    J Virol; 1993 Jan; 67(1):213-21. PubMed ID: 8416370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
    Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
    J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
    Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
    Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein.
    Iwatani Y; Ueno T; Nishimura A; Zhang X; Hattori T; Ishimoto A; Ito M; Sakai H
    Virus Res; 2001 Apr; 74(1-2):75-87. PubMed ID: 11226576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.
    Piller SC; Dubay JW; Derdeyn CA; Hunter E
    J Virol; 2000 Dec; 74(24):11717-23. PubMed ID: 11090171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity.
    Blot G; Janvier K; Le Panse S; Benarous R; Berlioz-Torrent C
    J Virol; 2003 Jun; 77(12):6931-45. PubMed ID: 12768012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4
    Fernandez-de Céspedes MV; Hoffman HK; Carter H; Simons LM; Naing L; Ablan SD; Scheiblin DA; Hultquist JF; van Engelenburg SB; Freed EO
    J Virol; 2022 Dec; 96(23):e0087622. PubMed ID: 36354340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
    Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
    J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.
    Tedbury PR; Ablan SD; Freed EO
    PLoS Pathog; 2013; 9(11):e1003739. PubMed ID: 24244165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.